COMPANY SUMMARY
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Financial Summary
| Share Statistics |
WAT |
Industry Median |
Percentile (All Stocks) |
| Market Cap (Mil) |
$39,760.0 |
$3,076.5 |
92% |
|
| Shares Out (Mil) |
98.2 |
96.5 |
61% |
|
| Institutional Ownership |
99.9% |
90.0% |
96% |
|
| Float (Mil) |
98.1 |
71.5 |
60% |
|
| Beta |
1.18 |
1.22 |
70% |
|
| Avg Daily Volume (000s) |
786 |
710 |
66% |
|
Price Change (52-week) |
35.9% |
89.4% |
72% |
|
| Growth |
WAT |
Industry Median |
Percentile (All Stocks) |
| Sales (5yr) |
6.0% |
7.8% |
41% |
|
| Net Income (5yr) |
4.3% |
(13.7%) |
46% |
|
| EPS (5yr) |
5.2% |
0.7% |
39 |
|
| Dividends (5yr) |
0.0% |
0.0% |
0% |
|
| Cash Flow (5yr) |
22.0% |
(15.0%) |
81% |
|
| Estimates |
Qtrly |
Current Fiscal Year |
Next Fiscal Year |
| # of Estimates |
21 |
24 |
24 |
| Current EPS |
$4.000 |
$14.576 |
$16.564 |
| Month Ago EPS |
$3.992 |
$14.513 |
$16.490 |
| # Rev Up |
1 |
1 |
0 |
| # Rev Down |
0 |
0 |
0 |
| Three Months Ago EPS |
$3.985 |
$14.502 |
$16.414 |
| Year/Year Chg |
(387.8%) |
35.5% |
72.6% |
| Financials |
WAT |
Industry Median |
Percentile (All Stocks) |
| Sales (TTM) (Mil) |
$4,644 |
$800 |
73% |
|
| Net Income (TTM) (Mil) |
$167 |
($31) |
66% |
|
| EPS (TTM) |
$2.228 |
($0.300) |
73% |
|
| Operating Cash Flow (TTM) (Mil) |
$550 |
$47 |
72% |
|
| Net Cash Flow (TTM) (Mil) |
$172 |
$5 |
83% |
|
| Long-Term Debt (Q1) (Mil) |
$5,208 |
$270 |
86% |
|
| Enterprise Value (Q1) (Mil) |
$45,824 |
$3,795 |
91% |
|
| Valuation |
WAT |
Industry Median |
Percentile (All Stocks) |
| P/B |
2.62 |
3.68 |
60% |
|
| P/E |
182.7 |
39.8 |
97% |
|
| Dividend Yield |
0.0% |
0.0% |
0% |
|
| PEG (5yr hist) |
35.1 |
5.5 |
99% |
|
| Ratios |
WAT |
Industry Median |
Percentile (All Stocks) |
| Gross Margin |
56.3% |
47.7% |
69% |
|
| Net Margin |
3.6% |
(3.2%) |
43% |
|
| ROA |
1.1% |
(4.3%) |
48% |
|
| ROE |
1.9% |
(7.9%) |
38% |
|
| Liabilities to Assets |
38.6% |
42.0% |
29% |
|
| F-Score |
4 |
5 |
34% |
|
Passing Stock Screens
As of 8/20/2026, from a list of 60 stock screening strategies,
WAT meetings the criteria of 1 screen:
Stock Screen
GURU STRATEGY
Lakonishok Screen
Factors: Value, Momentum
Identifying stocks trading at a discount to their industry norms but showing recent price strength and upward earnings revisions.